Your browser doesn't support javascript.
loading
Neonatal Myocardial Infarction: A Proposed Algorithm for Coronary Arterial Thrombus Management.
El-Sabrout, Hannah; Ganta, Srujan; Guyon, Peter; Ratnayaka, Kanishka; Vaughn, Gabrielle; Perry, James; Kimball, Amy; Ryan, Justin; Thornburg, Courtney D; Tucker, Suzanne; Mo, Jun; Hegde, Sanjeet; Nigro, John; El-Said, Howaida.
Affiliation
  • El-Sabrout H; Division of Pediatric Cardiology (H. El-Sabrout, P.G., K.R., G.V., J.P., S.H., H. El-Said), Rady Children's Hospital/University of California, San Diego.
  • Ganta S; Division of Pediatric Cardiac Surgery (S.G., J.N.), Rady Children's Hospital/University of California, San Diego.
  • Guyon P; Division of Pediatric Cardiology (H. El-Sabrout, P.G., K.R., G.V., J.P., S.H., H. El-Said), Rady Children's Hospital/University of California, San Diego.
  • Ratnayaka K; Division of Pediatric Cardiology (H. El-Sabrout, P.G., K.R., G.V., J.P., S.H., H. El-Said), Rady Children's Hospital/University of California, San Diego.
  • Vaughn G; Division of Pediatric Cardiology (H. El-Sabrout, P.G., K.R., G.V., J.P., S.H., H. El-Said), Rady Children's Hospital/University of California, San Diego.
  • Perry J; Division of Pediatric Cardiology (H. El-Sabrout, P.G., K.R., G.V., J.P., S.H., H. El-Said), Rady Children's Hospital/University of California, San Diego.
  • Kimball A; Division of Neonatology (A.K.), Rady Children's Hospital/University of California, San Diego.
  • Ryan J; 3D Innovation Lab (J.R.), Rady Children's Hospital/University of California, San Diego.
  • Thornburg CD; Division of Hematology (C.D.T.), Rady Children's Hospital/University of California, San Diego.
  • Tucker S; Division of Pathology (S.T., J.M.), Rady Children's Hospital/University of California, San Diego.
  • Mo J; Division of Pathology (S.T., J.M.), Rady Children's Hospital/University of California, San Diego.
  • Hegde S; Division of Pediatric Cardiology (H. El-Sabrout, P.G., K.R., G.V., J.P., S.H., H. El-Said), Rady Children's Hospital/University of California, San Diego.
  • Nigro J; Division of Pediatric Cardiac Surgery (S.G., J.N.), Rady Children's Hospital/University of California, San Diego.
  • El-Said H; Division of Pediatric Cardiology (H. El-Sabrout, P.G., K.R., G.V., J.P., S.H., H. El-Said), Rady Children's Hospital/University of California, San Diego.
Circ Cardiovasc Interv ; 15(5): e011664, 2022 05.
Article in En | MEDLINE | ID: mdl-35485231
ABSTRACT

BACKGROUND:

Neonatal myocardial infarction is rare and is associated with a high mortality of 40% to 50%. We report our experience with neonatal myocardial infarction, including presentation, management, outcomes, and our current patient management algorithm.

METHODS:

We reviewed all infants admitted with a diagnosis of coronary artery thrombosis, coronary ischemia, or myocardial infarction between January 2015 and May 2021.

RESULTS:

We identified 21 patients (median age, 1 [interquartile range (IQR), 0.25-9.00] day; weight, 3.2 [IQR, 2.9-3.7] kg). Presentation included respiratory distress (16), shock (3), and murmur (2). Regional wall motion abnormalities by echocardiogram were a key criterion for diagnosis and were present in all 21 with varying degrees of depressed left ventricular function (severe [8], moderate [6], mild [2], and low normal [5]). Ejection fraction ranged from 20% to 54% (median, 43% [IQR, 34%-51%]). Mitral regurgitation was present in 19 (90%), left atrial dilation in 15 (71%), and pulmonary hypertension in 18 (86%). ECG was abnormal in 19 (90%). Median troponin I was 0.18 (IQR, 0.12-0.56) ng/mL. Median BNP (B-type natriuretic peptide) was 2100 (IQR, 924-2325) pg/mL. Seventeen had documented coronary thrombosis by cardiac catheterization. Seventeen (81%) were treated with intracoronary tPA (tissue-type plasminogen activator) followed by systemic heparin, AT (antithrombin), and intravenous nitroglycerin, and 4 (19%) were treated with systemic heparin, AT, and intravenous nitroglycerin alone. Nineteen of 21 recovered. One died (also had infradiaphragmatic total anomalous pulmonary venous return). One patient required a ventricular assist device and later underwent heart transplant; this patient was diagnosed late at 5 weeks of age and did not respond to tPA. Nineteen of 21 (90%) regained normal left ventricular function (ejection fraction, 60%-74%; mean, 65% [IQR, 61%-67%]) at latest follow-up (median, 6.8 [IQR, 3.58-14.72] months). Two of 21 (10%) had residual trivial mitral regurgitation. After analysis of these results, we present our current algorithm, which developed and matured over time, to manage neonatal myocardial infarction.

CONCLUSIONS:

We experienced a lower mortality rate for infants with neonatal infarction than that reported in the literature. We propose a post hoc algorithm that may lead to improvement in patient outcomes following coronary artery thrombus.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Thrombosis / Mitral Valve Insufficiency / Myocardial Infarction Type of study: Etiology_studies / Prognostic_studies Limits: Humans / Infant / Newborn Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Thrombosis / Mitral Valve Insufficiency / Myocardial Infarction Type of study: Etiology_studies / Prognostic_studies Limits: Humans / Infant / Newborn Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2022 Type: Article